ÂÜÀòÂÒÂ×

As Chief Financial Officer for Marengo Therapeutics, Svetlana Makhni, brings more than 15 years of experience in finance, business development and operations in the biopharmaceutical industry. She previously served as Chief Financial Officer at Escient Pharmaceuticals, a clinical-stage biotech company, and before that, she was Chief Financial Officer and Head of Operations at Bierman ABA, a leading national, multi-site provider of behavioral health services. Prior to joining Bierman, she worked for nearly a decade in healthcare investment banking at several top financial institutions including BMO Capital Markets, Goldman Sachs, Westbrook Partners and the Blackstone Group.

Ms. Makhni earned her B.S. in Finance and Accounting from The Wharton School and her MBA from Harvard Business School.